Tag: canadian cannabis

April 23, 2020

Matica Announces Delayed Filing of Annual Disclosure Documents Pursuant to OSC Blanket Instrument 51-502

Matica Enterprises Inc. (CSE:MMJ) (Frankfurt:39F) (OTCQB:MMJFF) will be delaying the filing and delivery of certain of its continuous disclosure documents.
April 20, 2020

CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates

CB2 Insights (CSE:CBII; OTCQB: CBIIF) has completed the terms of the purchase agreement of Colorado-based Rae of Sunshine Health Services.
April 15, 2020

CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief Under COVID-19 Duress

CB2 Insights (CSE:CBII), has announced that due to circumstances created by the COVID – 19 pandemic, it will not be...
March 30, 2020

CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

Free interactive tool allows industry players to gain immediate insights derived from CB2 Insights aggregated and anonymized clinical outcome data.
March 3, 2020

Ignite International Brands Adds Thomas Kofman to its Board of Directors

Ignite International Brands, Ltd. announces appointment of Mr. Thomas Kofman to its board of directors.
March 2, 2020

Ignite International Brands Closes Licensing Agreement With Namaste’s CannMart

IGNITE and CannMart Announce the Launch of IGNITE Branded Cannabis and Cannabis 2.0 Offerings and Accessories in the Canadian Marketplace.
February 25, 2020

Matica Subsidiary Receives Sales Licence

Matica is pleased to announce that its subsidiary has received both the Standard Processing and Sale For Medical Purposes Licences...